Evolution of the Average Target: ALS Limited

Evolution of the Average Target - ALS Limited

Evolution of the Target Price: ALS Limited

Evolution of the Target Price - ALS Limited

Changes in Analyst Recommendations: ALS Limited

385eb521b34ad3a76bf.8tTvzykrDHUL77HZeadVbuup6VSneY4QRw8Dk9btG64.yr7f9ktMRRFSvt2WQNQTD9qa3TL_Tr9bBjth0ZWpc9-xp5uCSh1lP2mw-A~8a8df8315a32d18a2fbc60400154d2a6
06-15 Mining Services Sector Too Strong for Transitory, Manageable Issues, Says Jefferies MT
01-14 Evans & Partners Starts ALS at Positive with AU$25.80 Price Target MT
11-17 ALS Expected to Disclose 'Strong' Fiscal H2 Guidance, Says Jefferies. MT
31/10/25 ALS' Exploration Activity to Pick Up Amid Gold, Copper Boom, Jefferies Says MT
09/09/25 Barrenjoey Markets Upgrades ALS to Overweight from Neutral; Price Target is AU$20.95 MT
29/05/25 ALS' AU$390 Million Equity Raise 'Opportunistic,' Says Jarden MT
28/05/25 Jarden Adjusts ALS' Price Target to AU$14.60 from AU$15, Keeps at Underweight MT
23/05/25 Jarden Research Downgrades ALS to Underweight from Neutral, Adjusts Price Target to AU$15 from AU$14.50 MT
21/11/24 ALS Set for Potential Upside to Earnings Outlook, Jarden Research Says MT
20/11/24 Jarden Downgrades ALS to Neutral from Overweight, Adjusts Price Target to AU$14.40 from AU$14.25 MT
23/09/24 ALS Geochemistry Business Volumes Deteriorating, But Life Sciences Unit Remains Resilient, Says Jarden Research MT
20/09/24 Jarden Research Adjusts ALS' Price Target to AU$14.20 from AU$14.90; Keeps at Overweight MT
22/07/24 UBS Upgrades ALS Limited to Buy From Neutral; Price Target is AU$17 MT
22/05/24 Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70 MT
02/04/24 Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 MT
26/03/24 Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy MT
22/03/24 Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy MT
25/08/22 UBS Adjusts ALS' Price Target to AU$13.15 From AU$13.10, Keeps at Neutral MT
02/03/22 UBS Adjusts ALS' Price Target to AU$13.30 From AU$13.50, Keeps at Neutral MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.35%
+4.93%
+2.83%
+23.03%
+0.4%
+26.28%
+66.59%
+16.86%
+14.52%
+21.94%
Average +19.67%
Weighted average by Cap. +10.10%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
20.07AUD
Average target price
24.10AUD
Spread / Average Target
+20.06%
High Price Target
28.05AUD
Spread / Highest target
+39.76%
Low Price Target
16.70AUD
Spread / Lowest Target
-16.79%

Analyst Consensus Detail

Analyst consensus - ALS Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - ALS Limited
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - ALS Limited
  1. Stock Market
  2. Stocks
  3. ALQ Stock
  4. Consensus ALS Limited